What is Curative?
Curative is fundamentally altering the health insurance paradigm by introducing a first-of-its-kind employer-based plan that emphasizes accessibility and proactive member guidance. Holding an AM Best rating of A-, the company distinguishes itself by removing traditional financial hurdles, such as copays and deductibles, to ensure that members can engage with their health journey without hesitation. By offering competitive monthly premiums and a streamlined, value-driven experience, Curative addresses the systemic inefficiencies often found in legacy insurance models. Its market position is defined by a commitment to patient-centric care, effectively bridging the gap between high-quality medical services and affordable, predictable employer-sponsored coverage.
How much funding has Curative raised?
Curative has raised a total of $150M across 1 funding round:
Series B
$150M
Series B (2025): $150M with participation from JAM Fund
Key Investors in Curative
JAM Fund
JAM Fund is a venture capital firm that focuses on supporting high-growth startups, often leveraging deep operational expertise to help founders scale their businesses effectively.
What's next for Curative?
With the successful closure of this major strategic investment, Curative is poised to enter a phase of aggressive market penetration and operational scaling. The company is expected to utilize these funds to enhance its digital infrastructure, further refining the member experience and expanding its network of providers. As the firm continues to challenge established industry incumbents, the focus will likely shift toward increasing its market share among mid-to-large scale employers who are seeking to optimize their benefits packages while controlling long-term healthcare costs. Future growth will be contingent upon the company's ability to maintain its high service standards while navigating the complexities of the evolving regulatory environment in the United States healthcare market.
See full Curative company page
